sellModerate
KKR Phorm Investors L.P. sold $125M of TGAN
owner at Transphorm, Inc.. 24,411,968 shares at an average of $5.10, traded Jun 20, 2024, filed Jun 20, 2024.
Warning score
57Value
$125M
24,411,968 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$124.5M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001140361-24-030747, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | SOpen-market sale Common Stockindirect: See footnotes | -24,411,968 | $5.10 | $125M | 0 | Jun 20, 2024 |
Related signals
Other insiders at Transphorm, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 3Weak | Transphorm, Inc. | Katharina G. McFarland director | $20k 3,996 shares | -5% | |
| 3Weak | Transphorm, Inc. | Kelly Smales director | $20k 3,996 shares | -5% | |
| 3Weak | Transphorm, Inc. | Katharina G. McFarland director | $4,074 840 shares | -1% | |
| 3Weak | Transphorm, Inc. | Kelly Smales director | $2,304 475 shares | -1% | |
| 0Weak | Transphorm, Inc. | Kelly Smales director | $3,753 766 shares | -1% | |
| 45Moderate | Transphorm, Inc. | Primit Parikh PRESIDENT AND CEO | $29k 6,000 shares | -1% | |
| 10Weak | Transphorm, Inc. | Katharina G. McFarland director | $19k 3,996 shares | -5% | |
| 10Weak | Transphorm, Inc. | Kelly Smales director | $19k 3,996 shares | -5% | |
| 3Weak | Transphorm, Inc. | Katharina G. McFarland director | $4,015 833 shares | -1% | |
| 3Weak | Transphorm, Inc. | Kelly Smales director | $2,271 471 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.